Peripheral Arterial Disease Treatment Market Set to Surge to USD 6.4 Billion by 2035 Amid Rising Disease Burden

WILMINGTON, DE, UNITED STATES, October 8, 2025 /EINPresswire.com/ -- The global Peripheral Arterial Disease Treatment Market was valued at USD 2.9 billion in 2024 and is projected to reach approximately USD 6.4 billion by 2035, expanding at a CAGR of around 7.5% during the forecast period. Growth is driven by the increasing prevalence of diabetes, obesity, and cardiovascular diseases, along with a rapidly aging global population. Rising demand for minimally invasive endovascular procedures, such as angioplasty, atherectomy, and stenting, combined with technological advancements like drug-coated balloons and bioabsorbable stents, is significantly improving patient outcomes. Furthermore, growing healthcare investments and enhanced access to advanced vascular care in emerging economies are expected to propel market expansion over the coming decade.

Peripheral arterial disease (PAD) occurs when narrowed arteries reduce blood flow to the limbs, leading to pain, mobility issues, and increased risk of heart attack and stroke. The rising prevalence of diabetes and obesity, sedentary lifestyles, and smoking are major contributing factors to the growing incidence of PAD. The market for PAD treatment includes drug therapies, angioplasty and stenting, atherectomy devices, bypass surgery, and lifestyle modification programs.

Download Your Report Sample – Preview Market Opportunities: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86559

Key Players:

• Bayer AG
• Pfizer Inc.
• Eli Lilly and Company
• Cipla
• Lupin
• Viatris Inc
• Johnson & Johnson
• Sanofi
• Novartis AG
• Amgen Inc.
• Aurobindo Pharma

The growing adoption of minimally invasive endovascular procedures, coupled with the introduction of drug-eluting stents and balloons, is transforming treatment outcomes for PAD patients. Moreover, technological advancements and strong R&D investments by medical device companies are enhancing the availability of innovative therapeutic solutions.

Key Market Drivers

Increasing Prevalence of Diabetes and Cardiovascular Diseases

The growing incidence of diabetes and obesity worldwide significantly elevates the risk of developing PAD. According to the International Diabetes Federation, over 540 million adults are living with diabetes globally, many of whom are predisposed to vascular complications. This creates a strong demand for advanced diagnostic and therapeutic solutions.

Aging Population and Lifestyle Factors

The global geriatric population is expanding rapidly, and elderly individuals are more susceptible to peripheral artery blockages. Sedentary lifestyles, poor dietary habits, and high tobacco consumption further exacerbate disease incidence, fueling market expansion.

Technological Advancements in Endovascular Devices

The PAD treatment landscape is witnessing rapid technological innovations, such as drug-coated balloons, self-expanding stents, atherectomy systems, and imaging-guided procedures. These advancements reduce restenosis rates and improve procedural success, making endovascular therapy the preferred choice over open surgery.

Rising Healthcare Expenditure and Access to Care

Government initiatives to enhance cardiovascular disease management, coupled with increasing healthcare investments in emerging economies, are driving adoption of PAD treatment solutions. The expansion of healthcare infrastructure in countries such as India, China, and Brazil is expected to provide lucrative growth opportunities.

Market Challenges

Despite promising growth prospects, the market faces certain challenges such as:
High cost of advanced treatment devices, limiting adoption in low-income regions.
Limited awareness among patients about PAD symptoms and early diagnosis.
Reimbursement gaps for novel devices and procedures in developing healthcare systems.
Addressing these barriers through patient education, cost-effective innovations, and favorable reimbursement frameworks remains crucial for sustained market growth.

By Region:

North America (U.S., Canada)

Europe (U.K., Germany, France, Italy, Spain, Rest of Europe)

Asia Pacific (China, Japan, India, South Korea, Australia)

Latin America (Brazil, Mexico, Argentina)

Middle East & Africa (GCC, South Africa, Rest of MEA)

Regional Insights

North America holds a dominant position in the global PAD treatment market due to a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and strong reimbursement policies. The U.S. remains a major revenue contributor owing to the widespread adoption of minimally invasive treatments and a growing base of diabetic patients.

Europe follows closely, supported by the presence of key medical device manufacturers, increasing awareness of early PAD management, and government-backed screening programs.

Asia Pacific is anticipated to register the fastest growth during the forecast period. Rising healthcare investments, large diabetic populations, and expanding medical tourism in countries such as India and China are propelling regional market development. Moreover, improving access to advanced interventional cardiology procedures in urban centers further drives demand.

Market Trends

Shift Toward Minimally Invasive Procedures

Endovascular treatments such as angioplasty, atherectomy, and stenting are replacing traditional surgical methods due to their shorter recovery times and reduced risk of complications.

Integration of Artificial Intelligence (AI) and Imaging Technologies

AI-driven diagnostic imaging and vascular navigation systems are enhancing precision in PAD detection and intervention planning.

Drug-Eluting and Bioabsorbable Technologies

The introduction of drug-eluting balloons and bioabsorbable stents is revolutionizing long-term treatment outcomes by minimizing restenosis and eliminating the need for permanent implants.

Growing Focus on Preventive Care

Healthcare providers are emphasizing lifestyle modifications and patient education to prevent PAD progression, supported by digital health monitoring platforms.

Future Outlook

The future of the Peripheral Arterial Disease Treatment Market looks promising, with continuous advancements in biocompatible materials, smart imaging systems, and precision-guided vascular therapies. Increasing focus on personalized medicine and integrated disease management programs is likely to enhance patient outcomes. Furthermore, favorable regulatory pathways and increasing adoption of telemedicine for remote vascular monitoring will support long-term growth.

More Trending Reports by Transparency Market Research –

Amyloidosis Therapeutics Market - https://www.transparencymarketresearch.com/amyloidosis-therapeutics-market.html

Ambulatory Infusion Centers Market - https://www.transparencymarketresearch.com/ambulatory-infusion-centers-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com

Atil Chaudhari
Transparency Market Research Inc.
+1 518-618-1030
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.